Status:
COMPLETED
Drug-drug Interaction Study of FYU-981 and Oxaprozin
Lead Sponsor:
Mochida Pharmaceutical Company, Ltd.
Collaborating Sponsors:
Fuji Yakuhin Co., Ltd.
Conditions:
Healthy
Eligibility:
MALE
20-35 years
Phase:
PHASE1
Brief Summary
This is an open-label, 2-period add-on study to assess the drug-drug interaction between FYU-981 and oxaprozin. The purpose of this study is to investigate the pharmacokinetics of each period in a sin...
Eligibility Criteria
Inclusion
- Adult healthy subjects
- Body mass index: \>=18.5 and \<25.0
Exclusion
- Subject with any disease or any history of disease that might be unsuitable for participation in the clinical study
Key Trial Info
Start Date :
November 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2017
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03350386
Start Date
November 2 2017
End Date
December 5 2017
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
P-One Clinic
Hachiōji, Tokyo, Japan, 192-0071